Editor: Lekshmy Balakrishnan

Volume 29, 12 issues
ISSN: 0165-6147

Imprint: Cell Press
Commenced publication 1979

Impact Factor: 10.4 (Source: Journal Citation Reports® 2006, Thomson Scientific)

See editorial board for all editors information

Description
Trends in Pharmacological Sciences is one of the leading monthly review journals in pharmacology and toxicology. Every issue of Trends in Pharmacological Sciences contains succinct articles on the most exciting recent developments in pharmacology and toxicology research: topics covered in the journal range from molecular to behavioural pharmacology, and from current techniques to theoretical pharmacology. Trends in Pharmacological Sciences has a prestigious Advisory Editorial Board that attest to the journal's established reputation as essential reading for all pharmacologists and toxicologists, from students to professors and directors.

Review articles published in Trends in Pharmacological Sciences are lively, well-illustrated and have been thoroughly peer reviewed to ensure a balanced representation of the literature. Opinion articles follow trends and innovative ideas whilst the update section is designed to highlight recent advances in a particular research field providing insight on the implications of the new developments as well as future perspectives and directions. Letters of interest to readers are also published. Careful editing of all articles ensures accessibility to the non-specialist without compromising depth or quality for the specialist. Articles are usually invited; however, if you are interested in submitting a manuscript please send a one page summary of your proposed article to the editor.

Click here to access content from this title and other Trends journals

2008 Subscriptions

Institutional online access: ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect.

Personal price: Order form
USD 214 for all countries except Europe, Japan and Iran
EUR 196 for European countries and Iran
JPY 23,800 for Japan

Institutional price: Order form
EUR 1,450 for European countries and Iran
JPY 201,200 for Japan
USD 1,622 for all countries except Europe, Japan and Iran

Conditions of sale & ordering procedures, and links to our regional sales offices.

Dispatch Dates
For an overview of recently-dispatched issues, see the Journal issue dispatch dates

Audience
All pharmacologists, toxicologists, clinical pharmacologists and medicinal chemists. All biomedical research scientists and clinicians with an interest in pharmacology.

Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.

For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest